You have no items in your shopping cart.
You have no items in your shopping cart.
Catalog Number | orb1738268 |
---|---|
Category | Small Molecules |
Description | Lornoxicam-d4 |
CAS Number | 1216527-48-8 |
Purity | 0.98 |
MW | 375.85 |
SMILES | OC=1C2=C(S(=O)(=O)N(C)C1C(NC3=C(C(=C(C(=N3)[2H])[2H])[2H])[2H])=O)C=C(Cl)S2 |
Formula | C13H6D4ClN3O4S2 |
Biological Activity | Lornoxicam-d4 is intended for use as an internal standard for the quantification of lornoxicam by GC- or LC-MS. Lornoxicam is a COX inhibitor and non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory and analgesic properties. It inhibits production of thromboxane B2 from arachidonic acid in HEL human erythroleukemic cells, which endogenously express COX-1, as well as inhibits LPS-induced formation of prostaglandin F1α from arachidonic acid in Mono-Mac-6 cells, which endogenously express COX-2. Lornoxicam reduces LPS-induced production of nitric oxide and IL-6 in cell-based assays with IC50 values of 65 and 54 µM, respectively. It reduces carrageenan-induced paw edema in rats when administered intravenously at doses ranging from 0.1 to 9 mg/kg. Formulations containing lornoxicam have been used in the management of postoperative pain. |
Storage | -20°C |
Note | For research use only |
Expiration Date | 12 months from date of receipt. |